Skip to main content

RheumNow Podcast – The Future of JAKs (6.5.20)

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com.

  1. Check my updated virtual video joint exam for rheumatologists - Video here> https://t.co/ZXEUKcw5mb 
  2. Tuesday Nite Rheumatology Grand Rounds – Update on Biosimilars. Features Dr. Jonathan Kay (UMass) https://rheumnow.com/video/update-biosimilars 
  3. CDC guidelines for Rx of Latent Tuberculosis; Preferred: A) 3 months of once-weekly INH plus rifapentine (3HP); B) 4 months of daily rifampin (4R); C) 3 months of daily INH plus rifampin (3HR) - Shorter, safer, effective with higher completion rates. https://t.co/a2iZczFTP2 
  4. 46,311 #RA patients from the Swedish Rheumatology Quality Register were assessed for venous thromboembolism (VTE) risk. Increasing Dz activity increased the VTE risk #EULAR2020 OP0034 https://t.co/vEjKMMsT0U https://t.co/rzMMI9PlsV 
  5. DCVAS study of 1338 ANCA-Assoc Vasculitis (#AAV) pts showed AAV onset after age 65yrs had a 2 fold higher mortality (HR 2.06) and higher damage indices and greater risk of systemic, CNS, CV and renal disease (compared to onset <65 yrs)  https://t.co/wUCm6D2K6l 
  6. Abbvie has filed applications with the FDA and EMA for Rinvoq (upadacitinib) as a potential Treatment of Adults with Active Psoriatic Arthritis. https://t.co/8mnOE4M2y1&nbsp;
  7. Voclosporin was Submitted to the FDA as a New Drug Application as a potential treatment for #lupusnephritis. https://t.co/G5fZLnx60l https://t.co/5VmKceLEB3&nbsp;
  8. FDA Approves Taltz for Non-Radiographic Axial Spondyloarthritis  https://rheumnow.com/news/fda-approves-taltz-non-radiographic-axial-spondyloarthritis  
  9. Preventing COVID - Masks, Meters and Eyewear  https://rheumnow.com/news/preventing-covid-masks-meters-and-eyewear   
  10. Hydroxychloroquine Postexposure Prophylaxis for COVID-19 Fails  https://rheumnow.com/news/hydroxychloroquine-postexposure-prophylaxis-covid-19-fails 
  11. Lancet has issued an almost retraction - an "Expression of Concern" alerting readers that many have voiced scientific concerns about the Lancet HCQ/CQ paper w/ more deaths. MORE DEATHS COULD HAVE BEEN FROM THE HCQ/CQ OR HCQ/CQ BEING USED IN SICKER PTS. https://t.co/saoE32qpuF

 

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

Disclosures
The author has received compensation as an advisor or consultant on this subject
×